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Abstract
Background
EAST syndrome is an autosomal recessive disorder caused by loss-of-function
mutations in the gene KCNJ10. Among the 14 pathogenic mutations described
so far, the p.R65P mutation stands out as the most frequent one and is particu-
larly associated with patients of Pakistani origin. As a result we aimed to estab-
lish the existence of a potential founder effect in the Pakistani population.
Methods
To this end, we genotyped 12 patients from seven families and we compared
disease haplotypes with ethnically matched control chromosomes. This haplo-
type was used together with demographic data for Pakistan to estimate the age
of this founder mutation.
Results
We identified a small homozygous 0.694 Mb region around the KCNJ10
p.R65P mutation that had identical haplotypes in all of the patients which were
completely absent in the control sample. Based on current demographic data
and knowledge about disease frequency, we estimate that this particular p.R65P
mutation arose 20 generations (about 500 years) ago.
Conclusion
By knowing the prevalent mutation in a given population more efficient diag-
nostics can be performed and the families can benefit from specific counseling.
Introduction
EAST syndrome (OMIM #612780) is an autosomal reces-
sive disorder characterized by the combination of Epi-
lepsy, Ataxia, Sensorineural deafness, and renal salt-
wasting Tubulopathy (Bockenhauer et al. 2009; Scholl
et al. 2009). The disease is caused by recessive mutations
in the gene KCNJ10 (also known as inwardly rectifying
potassium channel, subfamily J, member 10 or Kir4.1)
(Bockenhauer et al. 2009; Scholl et al. 2009, 2012; Rei-
chold et al. 2010; Freudenthal et al. 2011; Cross et al.
2013; Parrock et al. 2013), expressed in the kidney, cen-
tral nervous system, ear, and eye (Takumi et al. 1995; Ito
et al. 1996; Kofuji et al. 2000; Marcus et al. 2002;
Tanemoto et al. 2004; Bockenhauer et al. 2009). In the
kidney, KCNJ10 is located in the distal nephron’s basolat-
eral membrane where the dysfunction of this potassium
channel leads to impaired salt reabsorption (Bockenhauer
et al. 2009; Scholl et al. 2009; Reichold et al. 2010). The
spectrum and severity of symptoms vary across identified
EAST cases as well as among the members of the same
family (Cross et al. 2013).
Fourteen different pathogenic mutations have been
reported so far in KCNJ10. The missense mutation
c.194G>C, replacing arginine with proline at the position
65 in the protein structure (p.R65P), is the most frequent
mutation reported so far (Bockenhauer et al. 2009; Scholl
et al. 2009, 2012; Reichold et al. 2010; Freudenthal et al.
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2011; Cross et al. 2013; Parrock et al. 2013). The
homozygous KCNJ10 p.R65P mutation was first described
in four Pakistani patients from a consanguineous family
and subsequently has been found in several other families
sharing the same ethnic background (Bockenhauer et al.
2009). In one case with mixed ethnic background, the
p.R65P mutation has been reported in a compound
heterozygous state, in association with a nonsense muta-
tion (Scholl et al. 2009; Reichold et al. 2010). The argi-
nine in position 65 of the KCNJ10 protein is located in
the first transmembrane motif of the channel; it is highly
conserved and essential for its transport function, as
shown by consistent experimental evidence (Bockenhauer
et al. 2009; Reichold et al. 2010; Sala-Rabanal et al. 2010;
Tang et al. 2010; Williams et al. 2010; Zdebik et al. 2013;
Chen and Zhao 2014). The mutation causes the loss of
>80% of protein’s transport activity (Sala-Rabanal et al.
2010; Bandulik et al. 2011; Freudenthal et al. 2011). The
very same amino acid is affected by another substitution,
replacing the arginine with a cysteine, in an Algerian
family with EAST syndrome (Freudenthal et al. 2011).
Knowing the prevalent mutation in a population has a
significant impact on efficient diagnosis and specific
counseling of affected families. As all the Pakistani
patients investigated so far by our group are homozygous
for p.R65P mutation, we considered the possibility of a
founder effect in this population and we set to estimate
its age. To our knowledge, no founder effect has been
reported so far in EAST syndrome patients.
Methods
Patients
We utilized DNA samples from 12 EAST syndrome
patients, six females and six males, with previously con-
firmed homozygous KCNJ10 (GenBank reference
sequence and version number: NG_016411.1; Gene ID:
3766) p.R65P mutation, and from four of their parents.
These patients came from seven families and were the
outcome of first cousin marriages of parents from Pak-
istani heritage. Two of the seven families were known also
to be distantly related. Genetic studies were approved by
the Institute of Child Health–Great Ormond Street
Hospital Research Ethics Committee and the parents pro-
vided written informed consent.
Whole genome SNP genotyping
The samples were genotyped using the Infinium Human-
Core-24 Beadchip, on an Illumina (San Diego, CA) plat-
form, according to the manufacturer’s recommendations.
The genotype data were subjected to quality controls,
which included filtering noninformative markers, geno-
type errors, and biased markers according to extreme
minor allele frequencies for the Pakistani population.
Haplotype reconstruction
Whole genome haplotype analysis was performed using
Allegro as described previously (Bockenhauer et al. 2009).
The individual alleles corresponding to the SNPs located
on the long arm of chromosome 1, in the KCNJ10 region,
were imported into an Excel spreadsheet, and manual
detection of a common disease haplotype for each EAST
case was done by looking at shared arrangements of alle-
les among cases. By visual comparison, we determined
the longest region of homozygosity shared by all the
patients. Genetic position of the individual markers used
in the analysis was obtained from The Human Genome
Working Draft (http://genome.ucsc.edu/) and genetic dis-
tances calculated based on the estimation that
1 Mbp = 1 cM (Kent et al. 2002). We obtained haplo-
types for 96 controls as well as the allelic frequencies for
the Pakistani population from The 1000 Genome Project
(www.1000genomes.org). We selected data corresponding
to the Punjabi population as this is the main population
in Pakistan, and therefore representative for our study
(Taus-Bolstad 2003; International Organisation for
Migration, 2006).
Statistical analysis
We compared the differences in allele frequencies between
mutant chromosomes and normal ethnically matched
chromosomes for the single markers within the disease
haplotype as well as for the whole haplotype using a chi-
square test or Fisher’s exact test, using Stata Statistical
Software, release 12 (StataCorp, 2011). In both cases, we
used a statistical threshold of 0.05. The control genotypes
obtained from the 1000 Genome Project were tested man-
ually to ensure no departure from Hardy–Weinberg equi-
librium using chi-square analysis and a statistical
threshold of 0.05.
Estimation of the age of the KCNJ10 p.R65P
mutation
To estimate the age of this mutation, we used DMLE+
v.2.3 software, a Bayesian linkage disequilibrium gene
mapping method that relies on linkage disequilibrium
between pathogenic mutations and multiple linked mark-
ers in patients and unrelated healthy controls (Reeve and
Rannala 2002). We estimated the Pakistani population
growth rate (r) using the formula N1 = N0e(gr), where
“N1” stands for the estimated population size today,
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“N0” is the estimated initial population size, and “g” the
number of generations between the two time points
(Vandermeer 2010). We estimated the disease allele fre-
quency in Pakistani population based on a disease inci-
dence of 1/100,000. We calculated the proportion of the
population sampled (f) as described by Rannala and
Slatkin (1998).
Results
Haplotype analysis
Haplotype analysis demonstrated a stretch of homozygos-
ity of 0.694 Mb, encompassing four SNPs, rs4282816,
rs2808661, rs6656979, and rs11577096, adjacent to the
KCNJ10 gene (Table 1). This haplotype was identical in
all patients and could be identified in heterozygous state
in the four genotyped parents. However, no match could
be found for this haplotype in the control sample. Taking
the flanking SNP markers into account identified a linked
locus containing six SNPs in total, rs2852727, rs4282816,
rs2808661, rs6656979, rs11577096, and rs7521304, cover-
ing an area of 1.255 Mb.
The haplotypes covering the same markers and the
same genetic distance were obtained from the 1000 Gen-
omes data and compared with the disease haplotype
observed both in patients and their relatives (Table 2).
The 192 chromosomes in the control set (96 samples) had
a total of 12 different configurations for the same block of
SNPs shared by the patients, none of which were identical
to the four SNP regions identified in our EAST syndrome
cases. The 96 ethnically matched controls were found to
be in Hardy–Weinberg equilibrium, thus confirming their
suitability for our study.
A Fisher’s exact test of the proposed common disease
haplotype in cases and controls produced a two-tailed
P value of less than 0.0001. Therefore, there is a statis-
tically significant difference in the frequency of the
common haplotype in cases versus controls. This differ-
ence was confirmed when we compared the allele fre-
quency of the six individual markers within the
analyzed haplotype as the frequencies were significantly
different in mutant chromosome compared to control
chromosomes.
Table 1. Genetic position from the six SNPs and KCNJ10 p.R65P
mutation for the observed founder haplotype.
SNP/mutation
Genetic distance from
rs2852727 in Morgans (M)
rs28527271 0.0
rs4282816 0.002059
rs2808661 0.004713
rs6656979 0.006952
rs11577096 0.009000
p.R65P 0.009554
rs75213041 0.012550
1Flanking markers.
KCNJ10 p.R65P mutation is given in bold (RefSeqGene NG_016411.1).
Table 2. Frequency of alleles within the founder haplotype for KCNJ10 p.R65P chromosomes and control chromosomes.
Marker Allele
Study group
P value3
Patients (24
chromosomes)
1000 Genomes PJL
controls2 (192
chromosomes)
N % N %
rs2852727 G1 23 96 105 55 0.0001
A 1 4 87 45
rs4282816 G1 24 100 75 39 <0.0001
A 0 0 117 61
rs2808661 A1 0 0 57 30 0.0008
G 24 100 135 70
rs6656979 C1 0 0 167 87 <0.0001
A 24 100 25 13
rs11577096 C1 0 0 172 90 <0.0001
T 24 100 20 10
rs7521304 T1 1 4 49 26 0.0194
G 23 96 143 74
1Reference allele. Alleles highlighted in gray correspond to the founder disease haplotype (KCNJ10 RefSeqGene NG_016411.1).
2PJL controls (Punjabis in Lahore), Pakistan, sequenced as part of the latest phase three variant set of The 1000 Genome Project.
3Two-tailed P value obtained from Fisher’s exact or chi-square analysis for one degree of freedom. Statistical threshold of 0.05 used. All P values
obtained were statistically significant.
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Estimating the age of p.R65P mutation
We estimated that the KCNJ10 p.R65P founder mutation
has been introduced into the Pakistani population around
20 generations ago (rounded to the closest generation)
with a 95% confidence interval (CI) between 17 and 25
generations. With each generation set to last 25 years, this
means that the mutation probably appeared 500 years ago
(95% CI: 425–625 years ago). Figure 1 shows a graphical
representation of the results obtained from DMLE+ soft-
ware with the histogram bars within the 95% confidence
interval colored in green.
The demographic parameters were calculated as
described in the Methods section and had the following
values: a population growth rate of 0.68/generation for a
current Pakistani population size of 190,337,989
(www.pwd.punjab.gov.pk) and a proportion of popula-
tion sampled of 0.00002. Based on an estimated incidence
of 1 in 100,000 EAST syndrome cases in Pakistan, we
could calculate the approximate values for the disease
prevalence and carrier frequency. Assuming that all the
cases in the Pakistani population are due to KCNJ10
p.R65P mutation, we inferred the frequency of the
mutant allele as being 0.316%, and the carrier frequency
as high as 1 (0.63%) in 159.
Discussion
This study provides evidence that the EAST syndrome
caused by KCNJ10 p.R65P mutation in Pakistani patients is
likely to be the result of a founder mutation that occurred
around 500 years ago. So far this is the only mutation
described in Pakistani patients with EAST syndrome.
Different missense, frameshift, and nonsense mutations
have been identified so far in KCNJ10 gene, in patients of
different ethnicities (Bockenhauer et al. 2009; Scholl et al.
2009, 2012; Freudenthal et al. 2011; Thompson et al.
2011). Most mutations are found in one or a few families.
However, all our patients of Pakistani descent are
homozygous for the missense mutation p.R65P. In order
to prove the founder effect we genotyped 12 patients and
four parents from seven British Pakistani families and we
Figure 1. Age of p.R65P mutation estimated by DMLE+ v.2.3 software based on the founder haplotype. Green bars delimit the 95% confidence
interval. x-axis: age of mutation in generations (one generation = 25 years). y-axis: frequency for each estimation out of a total of 10,000,000
iterations. The highest frequency was obtained for about 20 generations. The 95% confidence interval stretches from 17 to 25 generations.
524 ª 2016 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
EAST Syndrome O. Abdelhadi et al.
compared the haplotypes containing the KCNJ10 p.R65P
mutation. The same haplotype was present in homozy-
gous state in patients and heterozygous state in the four
parents, carriers for the disease. This haplotype was absent
in the control chromosomes. Given the high rate of con-
sanguinity in Pakistani population, we considered the
possibility that all the seven families might be related.
However, except for two of them being distantly related,
the other families had no identifiable connection,
strengthening the idea of a founder mutation. The
KCNJ10 p.R65P mutation has not been found in patients
from other ethnic background, further supporting the
hypothesis of a founder effect within the Pakistani popu-
lation.
The EAST syndrome is relatively recently described and
as rare disease might be still an underdiagnosed disease. This
is why we used in our study an estimated value of 1/100,000
for the disease incidence (Rannala and Slatkin 1998). If this
estimation is close to the truth, EAST syndrome might be
underdiagnosed in this population in Pakistan.
Mutation age calculation depends on a series of events
like demographic changes, disappearance or recurrence of
the same mutation in different, unrelated individuals,
selection, or recombination (Slatkin and Rannala 2000;
Rosenberg and Nordborg 2002). The algorithm included
in DMLE+ program takes all these factors into account
and the result is given in a range of confidence that
includes all these variations (Rannala and Slatkin 1998;
Reeve and Rannala 2002).
The demographic parameters have a significant impact
on mutation age determination, and for this reason we
chose more precise data, even if more recent, for our cal-
culations. Pakistan, as a country has a relatively short his-
tory, but it originates in one of the oldest ancestral
populations the Indus Valley Civilization, having a
reported estimated population size of 5,000,000 people at
its peak between 2500 and 1700 BCE (Kahn 2005). The
multiple migrations and redistributions in the area might
have had an impact both on the distribution of the muta-
tion and the actual growth rate over a longer time. Since
this ancient population seems to have founded most of
the populations of the Indian subcontinent, including
Pakistan, India, and Afghanistan, we chose to use more
precise data given by the first Pakistani census, in 1951,
to calculate the population growth rate (Kahn 2005).
However, given the fact that these data are only 2.5 gen-
erations old, we consider the fact that the result might
not reflect the complete evolution of the population. The
same limitations have been met by other studies attempt-
ing to investigate founder mutations within Pakistani
populations (Shaiq et al. 2012). Pakistan was part of the
British Indian Empire and gained independence in 1947.
This period of dissolution of the British Indian Empire
witnessed the largest mass migration in history with mil-
lions of Muslims living in India relocating to Pakistan
and millions of Hindus residing in Pakistan moving to
India (Haub and Sharma 2006). In our experience, only
Pakistani patients presented p.R65P mutation, supporting
separation of this population from the other populations
in South East Asia for the purpose of this study. Consid-
ering all these variations, we estimated that the KCNJ10
p.R65P mutation occurred about 500 years or 20 genera-
tions ago (17–25 generations confidence interval). Around
1550 AD corresponds to the early times of Mughal
Empire, ruled by a Turco-Mongol dynasty and covering
the actual territories of Pakistan, Afghanistan, India, and
Bangladesh. Lahore, the capital of the Punjab Province of
Pakistan, was for a short time the capital of Mughal
Empire in the 16th and early 17th centuries.
Conclusions
The presence of the KCNJ10 p.R65P mutation at high fre-
quency in patients of Pakistani descent only, associated
with an identical haplotype including the disease allele in
all affected individuals investigated by our team, strongly
supports the hypothesis of a founder effect within this
population. The origin of this mutation has been estimated
to have arisen around 500 years ago, before the latest
major migrations in the area. Knowledge about the genet-
ics of EAST syndrome and the prevalent mutation p.R65P
in this population supports targeted molecular diagnosis
and enables provision of appropriate genetic counseling,
particularly in a new disease like EAST syndrome.
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